The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival effect of darbepoetin alfa in patients with diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: The LNH03-6B study.
R. Delarue
No relevant relationships to disclose
C. Haioun
No relevant relationships to disclose
B. Coiffier
No relevant relationships to disclose
L. Fornecker
No relevant relationships to disclose
M. Fournier
No relevant relationships to disclose
N. Mounier
No relevant relationships to disclose
T. J. Molina
No relevant relationships to disclose
S. Bologna
No relevant relationships to disclose
C. Fruchart
No relevant relationships to disclose
S. Picard
No relevant relationships to disclose
H. Tilly
No relevant relationships to disclose
A. Bosly
No relevant relationships to disclose